🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Nice overview of trials and treatment advances in IgA nephropathy this morning at #GlomCon. Here's a modified KDIGO algorithm with some of these considerations below in this thread 🧵

Congratulations 💐 ⁦AIIMS Raipur⁩ for Started multiorgan donation and Deceased donor transplant at Govt hospital AIIMS RAIPUR ⁦vinay rathore⁩ ⁦NOTTO⁩ ⁦DGHSIndia⁩ ⁦ROTTO NORTH⁩ ⁦ROTTO-SOTTO MUMBAI⁩ ⁦AIIMS New Delhi⁩ ⁦drdeepakguptans⁩

Hey #Nephpearls followers #NephMadness 2️⃣🏀2️⃣3️⃣ is upon us‼️ LIKE ❤️ If this is the first time you’ve heard about it (if so, please click on link) RETWEET 🔄 If you’re going to participate Link 👉🏼 ajkdblog.org/2022/03/01/wel… via AJKD

Thanks for the overwhelming response to the #AINUKidneyrun Honoured to have the stalwarts in Nephrology participating🙏🙏🙏 Swarnalatha Guditi Dr Prof Manisha Sahay Dr P S Vali #WorldKidneyDay Srikanth Gundlapalli VARUN M sujeeth reddy bande Kranthi kumar

AINU Transplant Conclave in association with Hyderabad Nephrology Forum ! Join us to see the experts comment and deliberate on various topics on 13th and 14th May hyatt Place, Hyderabad AINU Nephrology Indian Society of Nephrology Int Society of Nephrology Srikanth Gundlapalli Dr P S Vali Srikanth Bathini VARUN M Navinath M

✨ Embracing luminous traditions, the #TransplantConclave 🌟 begins with a vibrant inauguration. Dr MV Rao sir gave inspiring opening remarks. Program director Srikanth Gundlapalli addressed the distinguished audience Asian Institute of Nephrology and Urology @ainunephrology

4th edition of AINU Kidney Run held on the eve of World Kidney Day was a huge success with over 1500 runners showing their support to spread awareness in kidney health ! Komatireddy Venkat Reddy garu flagged off the run 🏃‍♀️🙏🏻 360Life Enlightened Living Mercedes-Benz India Mahavir motors Thank you 🙏🏻

AINU Kidney Run "Optimising prescription practises" This #WorldKidneyDay AINU team promotes best prescription practises for optimal outcomes.. Creating awareness by annual running event..

🧵1/10 📢 New Definition in Nephrology Disease-Modifying Anti-Nephropathic Drugs (DMANDs) – A definition proposed by Immunonephrology Working Group (IWG) of the European Renal Association (ERA). Why does this matter? Let’s break it down! 🔗 doi.org/10.1093/ndt/gf… NDT An

🔴Approach to Resistant Hypertension⤵️ #2024Review #OpenAccess 🔹link.springer.com/article/10.100… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

💥 Game Changers in CKD and T2DM 💥 first up Peter Rossing on GLP1s ▶️Early CV studies suggested kidney benefits of GLP1s ▶️Flow trial designed to look at kidney outcomes in DKD 💥 Showed improvement in composite kidney outcomes, eGFR slope, cardiovascular outcomes and all

Presented at #ERA25: In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results:

#ERA25 #BeyondNephrology 1/And now one of the most awaited sessions in Late Breaking Clinical Trials 1: Cutting-Edge Clinical Trials in #Nephrology🥁 🚨 THE CONFIDENCE TRIAL: EFFICACY/SAFETY OF COMBINING FINERENONE WITH EMPAGLIFLOZIN IN PEOPLE WITH CHRONIC KIDNEY DISEASE AND

First in Novel CKD Treatments Beyond the Pillars (room K), Jonathan Barratt presenting 🥁Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart Zigakibart= humanized MAb that blocks

Team Salford Care Organisation Renal Department at #UKKW25

Delighted to see so many of our @salfordrenal colleagues speaking at #UKKW2025 inc Smeeta Sinha Helen Hurst tinachrys Tom McDonnell, Phil Kalra, Darren Green, Saif Al-Chalabi

GLP-1-based therapeutics for cardiorenal protection in metabolic diseases 🆓doi.org/10.1093/ndt/gf…

DAPA-Tolvaptan: First trial of SGLT2 inhibition in ADPKD with background tolvaptan therapy KIReports made it to the #TOM in this #ISNGTF May issue. See the latest #ISNGTF summary for details. VA by M Abdul Qader🇧🇩

Delighted to see our work from our advanced kidney care service published Ibrahim Ali Rosie Donne NCA Research NHS

1/10 Last #NephJC we discussed the combination therapy of empagliflozin and finerenone 💊 #TenPostNephJC 🌵From a therapeutic dessert to a flood of options in DKD - what is the best timing to keep the kidneys afloat